The antiviral tecovirimat is safe but did not improve clade I mpox resolution in Democratic Republic of the Congo NIH-cosponsored study examined tecovirimat in mpox-endemic country.

https://www.nih.gov/news-events/news-releases/antiviral-tecovirimat-safe-did-not-improve-clade-i-mpox-resolution-democratic-republic-congo